Literature DB >> 24752464

Cataract may be a non-memory feature of Alzheimer's disease in older people.

Shih-Wei Lai1, Cheng-Li Lin, Kuan-Fu Liao.   

Abstract

The aim of this study was to explore whether there is a relationship between cataract and Alzheimer's disease in older people in Taiwan. We conducted a retrospective cohort study by using the database of the Taiwan National Health Insurance Program from 1999 to 2004. There were 19,954 subjects aged 65-84 with newly diagnosed cataract as the cataract group and 19,954 randomly selected subjects without cataract as the non-cataract group. Both groups were matched with sex, age and index year of diagnosing cataract. The risk of Alzheimer's disease associated with cataract was assessed. The overall incidence of Alzheimer's disease was 1.21 per 1,000 person-years in the cataract group and 0.73 per 1,000 person-years in the non-cataract group (crude hazard ratio 1.62, 95 % CI 1.28, 2.04). After adjustment for potential confounders, the adjusted HR of Alzheimer's disease was 1.43 (95 % CI 1.13, 1.82) for the cataract group, compared to the non-cataract group. Male (HR 1.36, 95 % CI 1.09, 1.70), age (every 1 year, HR 1.08, 95 % CI 1.06, 1.10) and head injury (HR 1.79, 95 % CI 1.08, 2.96) were other factors significantly associated with Alzheimer's disease. Older people with cataract are at 1.43-fold increased risk of developing Alzheimer's disease. More research is necessary to determine whether cataract is one of non-memory features of Alzheimer's disease.

Entities:  

Mesh:

Year:  2014        PMID: 24752464     DOI: 10.1007/s10654-014-9903-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase.

Authors:  Andrey Y Abramov; Laura Canevari; Michael R Duchen
Journal:  J Neurosci       Date:  2004-01-14       Impact factor: 6.167

2.  Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Authors:  Lee E Goldstein; Julien A Muffat; Robert A Cherny; Robert D Moir; Maria H Ericsson; Xudong Huang; Christine Mavros; Jennifer A Coccia; Kyle Y Faget; Karlotta A Fitch; Colin L Masters; Rudolph E Tanzi; Leo T Chylack; Ashley I Bush
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

Review 3.  The new epidemiology of cataract.

Authors:  Alison G Abraham; Nathan G Condon; Emily West Gower
Journal:  Ophthalmol Clin North Am       Date:  2006-12

Review 4.  Global estimates of visual impairment: 2010.

Authors:  Donatella Pascolini; Silvio Paolo Mariotti
Journal:  Br J Ophthalmol       Date:  2011-12-01       Impact factor: 4.638

5.  Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.

Authors:  Shih-Wei Lai; Pei-Chun Chen; Kuan-Fu Liao; Chih-Hsin Muo; Cheng-Chieh Lin; Fung-Chang Sung
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

6.  Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.

Authors:  Antonio Di Carlo; Marzia Baldereschi; Luigi Amaducci; Vito Lepore; Laura Bracco; Stefania Maggi; Salvatore Bonaiuto; Egle Perissinotto; Guglielmo Scarlato; Gino Farchi; Domenico Inzitari
Journal:  J Am Geriatr Soc       Date:  2002-01       Impact factor: 5.562

7.  Mitochondria, cognitive impairment, and Alzheimer's disease.

Authors:  M Mancuso; V Calsolaro; D Orsucci; C Carlesi; A Choub; S Piazza; G Siciliano
Journal:  Int J Alzheimers Dis       Date:  2009-07-06

8.  Incidence of Alzheimer's disease in India: a 10 years follow-up study.

Authors:  P S Mathuranath; Annamma George; Neelima Ranjith; Sunita Justus; M Suresh Kumar; Ramsekhar Menon; P Shankara Sarma; Joe Verghese
Journal:  Neurol India       Date:  2012 Nov-Dec       Impact factor: 2.117

9.  Early-versus late-onset Alzheimer's disease: more than age alone.

Authors:  Esther L G E Koedam; Vivian Lauffer; Annelies E van der Vlies; Wiesje M van der Flier; Philip Scheltens; Yolande A L Pijnenburg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 10.  Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

Authors:  Mario F Mendez
Journal:  Arch Med Res       Date:  2012-11-21       Impact factor: 2.235

View more
  5 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Altered brain network centrality in patients with mild cognitive impairment: an fMRI study using a voxel-wise degree centrality approach.

Authors:  Jing Xiong; Chao Yu; Ting Su; Qian-Min Ge; Wen-Qing Shi; Li-Ying Tang; Hui-Ye Shu; Yi-Cong Pan; Rong-Bin Liang; Qiu-Yu Li; Yi Shao
Journal:  Aging (Albany NY)       Date:  2021-06-09       Impact factor: 5.682

3.  Visual Restoration after Cataract Surgery Promotes Functional and Structural Brain Recovery.

Authors:  Haotian Lin; Li Zhang; Duoru Lin; Wan Chen; Yi Zhu; Chuan Chen; Kevin C Chan; Yizhi Liu; Weirong Chen
Journal:  EBioMedicine       Date:  2018-03-07       Impact factor: 8.143

4.  Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.

Authors:  Elena L Paley; George Perry
Journal:  Nutrients       Date:  2018-03-26       Impact factor: 5.717

Review 5.  Environmental Enrichment and Successful Aging.

Authors:  Michael Leon; Cynthia Woo
Journal:  Front Behav Neurosci       Date:  2018-07-23       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.